5-Chloro-1-methylindolin-2-one

Catalog No.: 
ACRZXW903
CAS No.: 
41192-33-0
Molecular Formula: 
C9H8ClNO
Molecular Weight: 
181.62
5-Chloro-1-methylindolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$129.00In stockInquiry
250mg97%$219.00In stockInquiry
1g97%$591.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-1-methylindolin-2-one
IUPAC Name5-chloro-1-methylindolin-2-one
MDL No.MFCD18432286
Molecular FormulaC9H8ClNO
Molecular Weight181.62
SMILESO=C1N(C)C2=C(C=C(Cl)C=C2)C1
InChI KeyONTWHPOGWLOYFI-UHFFFAOYSA-N
Synonym5-CHLORO-1-METHYLINDOLIN-2-ONE;5-chloro-1-methyl-2,3-dihydro-1H-indol-2-one;2H-Indol-2-one, 5-chloro-1,3-dihydro-1-methyl-
CAS No.41192-33-0
PubChem CID10976112

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRZXW903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCTPZ694 route compound structure diagram
    ACCTPZ69417630-75-0In Stock
  2. Then
  3. ACRZXW903 route product structure diagram
    ACRZXW90341192-33-0In Stock
Inquiry

2. ACRZXW903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOCV291 route compound structure diagram
    ACGOCV29161-70-1In Stock
  2. Then
  3. ACRZXW903 route product structure diagram
    ACRZXW90341192-33-0In Stock
Inquiry

3. ACRZXW903 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCTPZ694 route compound structure diagram
    ACCTPZ69417630-75-0In Stock
  4. Then
  5. ACRZXW903 route product structure diagram
    ACRZXW90341192-33-0In Stock
Inquiry

Comments (0)